Longeveron (LGVN) Research & Development (2020 - 2026)

Longeveron's (LGVN) quarterly Research & Development came in at $2.3 million in Q1 2026, down 7.79% year-on-year from $2.5 million in Q1 2025, and down 14.74% quarter-over-quarter from $2.7 million in Q4 2025.

Longeveron (LGVN) Research & Development (2020 - 2026) Analysis & Trends

Longeveron's Research & Development history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 7.79% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was $11.8 million, a 40.48% increase from a year earlier, with the FY2025 full-year figure at $12.0 million, up 47.98% from the prior year.
  • Research & Development slipped to $2.3 million in Q1 2026 per LGVN's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Research & Development topped out at $3.9 million in Q3 2025 and bottomed at $234000.0 in Q2 2022.
  • The 5-year median for Research & Development is $2.2 million (2024), against an average of $2.2 million.
  • Across the five-year window, Research & Development soared 880.0% in 2022 and tumbled 33.93% in 2023, its largest moves.
  • Year by year, Research & Development stood at $3.3 million in 2022, then plunged by 33.93% to $2.2 million in 2023, then declined by 7.75% to $2.0 million in 2024, then soared by 36.75% to $2.7 million in 2025, then fell by 14.74% to $2.3 million in 2026.
  • Per Business Quant, the three latest LGVN Research & Development figures stand at $2.3 million (Q1 2026), $2.7 million (Q4 2025), and $3.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -17.94 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 1.46 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 541.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 961.60 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 1.54 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 15.66 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -443.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 343.97 Mn
10 Longeveron 14.87 Bn 14.86 Bn 264,000.00 2.32 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.32 Mn
Dec 31, 2025 2.72 Mn
Sep 30, 2025 3.85 Mn
Jun 30, 2025 2.95 Mn
Mar 31, 2025 2.52 Mn
Dec 31, 2024 1.99 Mn
Sep 30, 2024 2.21 Mn
Jun 30, 2024 1.72 Mn
Mar 31, 2024 2.22 Mn
Dec 31, 2023 2.16 Mn
Sep 30, 2023 1.84 Mn
Jun 30, 2023 2.29 Mn
Mar 31, 2023 2.78 Mn
Dec 31, 2022 3.26 Mn
Sep 30, 2022 245,000.00
Jun 30, 2022 234,000.00
Mar 31, 2022 1.29 Mn
Dec 31, 2021 -4.15 Mn
Sep 30, 2021 25,000.00
Jun 30, 2021 53,000.00